Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q3 2017)

As of Sep 30, 2017, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 14, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2017, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q3 2017
39115V101
Great Panther
Sell
-95,200
Q3 2017
A
Agilent Technologies, Inc.
Buy - Position Entry
+557,700
Q3 2017
AA
Alcoa Corporation
Sell
-783,800
Q3 2017
AAME
Atlantic American Corporation
Buy
+300
Q3 2017
AAON
AAON, Inc.
Buy
+16,950
Q3 2017
AAP
Advance Auto Parts Inc.
Buy - Position Entry
+115,350
Q3 2017
AAPL
Apple Inc.
Sell - Position Exit
-584,433
Q3 2017
AB
AllianceBernstein Holding L.P.
Buy
+91,600
Q3 2017
ABBNY
ABB Ltd.
Buy
+316,600
Q3 2017
ABBV
AbbVie Inc.
Sell
-1,812,500
Q3 2017
ABCB
Ameris Bancorp
Sell
-37,600
Q3 2017
ABEV
Ambev S.A.
Sell - Position Exit
-5,532,700
Q3 2017
ABG
Asbury Automotive Group Inc
Buy
+5,804
Q3 2017
ABM
ABM Industries Incorporated
Buy - Position Entry
+71,700
Q3 2017
ABR
Arbor Realty Trust
Sell
-253,804
Q3 2017
ABT
Abbott Laboratories
Sell - Position Exit
-1,065,566
Q3 2017
ABUS
Arbutus Biopharma Corporation
Sell
-49,629
Q3 2017
AC
Associated Capital Group, Inc.
Sell
-11,400
Q3 2017
ACCO
Acco Brands Corporation
Sell
-385,700
Q3 2017
ACIW
ACI Worldwide, Inc.
Sell
-150,000
Q3 2017
ACLS
Axcelis Technologies, Inc.
Sell - Position Exit
-63,099
Q3 2017
ACM
AECOM
Buy
+207,133
Q3 2017
ACNB
ACNB Corporation
Buy
+13,146
Q3 2017
ACNT
Ascent Industries Co.
Buy
+10,581
Q3 2017
ACRS
Aclaris Therapeutics, Inc.
Sell - Position Exit
-28,900
Q3 2017
ACTG
Acacia Research Corporation
Sell
-44,800
Q3 2017
ACU
Acme
Buy
+5,000
Q3 2017
ADAP
Adaptimmune Therapeutics plc
Buy
+85,800
Q3 2017
ADBE
Adobe Inc.
Buy
+84,300
Q3 2017
ADC
Agree Realty Corporation
Buy - Position Entry
+75,500
Page 1 of 66